Sign in to view content

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results

Jeffrey S. Heier, MD

Video
Published 2019

Jeffrey S. Heier, MD

AMD Non-neovascular Symposium

Related

Performance and Usability of a Self-Operated Home Optical Coherence Tomography (OCT) System: NOTAL-OCT V2.5 (NO V2.5)
Judy E. Kim, MD, FASRS
Annual Meeting Talks
2019
Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2019
Wieland-Khanani Port Delivery System
Mark R. Wieland, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field

Category: AMD-Non-Neovascular

See more